By G HossainPosted on June 26, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Jefferies expects Moderna to have around seven commercial products in the coming years which, along with a projected 10% revenue growth, could help the company break even in 2028. Moderna looks out to R&D ‘horizons’ as 2028 break-even goal looms Post navigation Merck KGaA inks $11B Bio-Techne buyout to expand into cell therapy productionBIO 2026: Making biotech IPOs great again and the forgotten pharma antitrust review